Join Now

Category Archives: COVID-19 Updates

Biden Supports IP Waiver for COVID-19 Vaccines

By Denise Bell | Published May 7, 2021

The Biden administration has announced that they will back a waiver of the WTO Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement so that any country can produce vaccines without worrying about patent infringement. This has the potential to drastically hinder global vaccine manufacturing and distribution and sets a dangerous precedent for future pandemics. The […]

Also posted in Policy News | | Leave a comment

Co-Diagnostics, Inc. JV CoSara Diagnostics Recognized for Work Combating COVID-19 Surge in India

By Denise Bell | Published April 30, 2021

Co-Diagnostics’ Indian manufacturing facility, CoSara Diagnostics Pvt. Ltd. (“CoSara,” or the “JV”, a Joint Venture with Synbiotics Ltd) has been featured in recent press highlighting its actions to provide COVID-19 diagnostics as a surge of infections has led to the world’s worst COVID-19 outbreak since the pandemic began. The article in the Times of India […]

Also posted in BioUtah News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

U.S. Study of DiscGenics IDCT Achieves One-Year Follow-Up Milestone

By Denise Bell | Published April 30, 2021

DiscGenics, a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine,  has completed enrollment in its Japanese safety study of Injectable Discogenic Cell Therapy (IDCT) for lumbar disc degeneration, a major cause of chronic low back pain. This Japanese 38-subject […]

Also posted in BioUtah News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

Canary Speech and Constant Companion Partner to Help Diagnose Behavioral Health Issues

By Denise Bell | Published April 30, 2021

Utah Business Magazine has highlighted a new partnership between Constant Companion and Canary Speech to study how voice technology can be used to identify human conditions in specific populations. Canary Speech will analyze the data with its patented speech digital biomarker technology, used to diagnose behavioral conditions and other diseases. Constant Companion will be utilizing its […]

Also posted in BioUtah News, Utah's Life Sciences Companies | | Leave a comment

UNIVERSITY OF UTAH, ARUP, AND TECHCYTE DEVELOP NANOSPOT.AI, A NEW ULTRA-FAST TEST FOR COVID-19 ANTIBODIES

By Denise Bell | Published April 30, 2021

The University of Utah (the U), ARUP Laboratories, and Techcyte Inc. announced that they have formed a partnership to develop NanoSpot.AI, a less than five-minute, easy-to-administer COVID-19 antibody test. NanoSpot.AI is estimated to be significantly less expensive to manufacture than other antibody tests, so it has the potential to be much more affordable and extend […]

Also posted in BioUtah News, Utah's Life Sciences Companies | | Leave a comment

PhotoPharmics Innovations Address Global Health Inequalities

By Denise Bell | Published April 16, 2021

PhotoPharmics has announced its intent to leverage its FDA breakthrough device designation, potential streamlined Medicare coverage under CMS’ pending Medicare Coverage of Innovative Technology (MCIT) rule and global delivery channels to deliver its treatments for Parkinson’s and neurodegenerative diseases to individuals regardless of their location or income. Innovation not only brings improved treatments to address […]

Also posted in BioUtah News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

SDP Oncology Presents New Data from Investigational Pipeline of Novel Cancer Therapeutics at AACR Virtual Annual Meeting I 2021

By Denise Bell | Published April 16, 2021

Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently presented new findings on a range of investigational agents from the company’s pipeline at the American Association for Cancer Research (AACR) Virtual Annual Meeting I. The data presented at the meeting include preclinical and Phase 1 clinical data evaluating the potential anti-cancer activity of the PKM2 activator […]

Also posted in BioUtah News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

Innovative Med Tech Startup Xenter Announces Company Launch

By Denise Bell | Published April 16, 2021

Xenter has announced its formal launch in Salt Lake City. Founded in 2020 by seasoned life sciences entrepreneur Richard J. Linder, Xenter is innovating new wireless technologies and techniques for the treatment of heart and vascular disease. The company’s next-generation devices will integrate functions that formerly required multiple costly devices. “We are bringing the world’s […]

Also posted in BioUtah News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

Utah’s Recursion Goes Public – Announces Pricing of IPO

By Denise Bell | Published April 16, 2021

Recursion Pharmaceuticals, Inc. today announced the pricing of its initial public offering of its Class A common stock at a price to the public of $18.00 per share. Recursion is offering 24,242,424 shares of its Class A common stock. The gross proceeds from the offering are expected to be $436.4 million. The shares are expected to […]

Also posted in BioUtah News, Industry News, Press Releases, Utah's Life Sciences Companies | | Leave a comment

IONIQ Sciences Announces Dr. Raphael E. Pollock Has Joined Its Medical Advisory Committee

By Denise Bell | Published April 9, 2021

IONIQ Sciences, Inc. recently announced that Raphael E. Pollock, MD, PhD, FACS has joined its Medical Advisory Committee. Dr. Pollock is an award-winning surgical oncologist, extensively published physician- scientist, Professor Emeritus in the Department of Surgical Oncology at MD Anderson Cancer Center and currently the Director of The Ohio State University Comprehensive Cancer Center (OSUCCC). […]

Also posted in BioUtah News, Industry News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

FDA Permits Marketing of BioFire COVID-19 Diagnostic Test Using Traditional Premarket Review Process

By Denise Bell | Published March 19, 2021

On March 17, the FDA granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of COVID-19 and other respiratory tract infections. The diagnostic test, which had an Emergency […]

Also posted in BioUtah News, HHS/FDA & Other Regulatory, Utah's Life Sciences Companies | | Leave a comment

President Biden Signs $1.9 Trillion COVID-19 Relief Bill

By Denise Bell | Published March 11, 2021

Yesterday, President Biden signed into law the American Rescue Plan (H.R. 1319), a $1.9 trillion COVID-19 relief package that Congress approved this week. On Wednesday, the House of Representatives approved the Senate-passed version of the bill by a vote of 220 to 211, with one Democrat joining all Republicans in voting against it. Rep. Jared […]

Also posted in COVID-19 Legislation, Federal News, Policy News | | Leave a comment

A Special Thanks To Our Elite Members